Proton Therapy denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for proton therapy are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Proton Therapy as Experimental — and Why You Can Appeal

An experimental or investigational denial means Aetna has determined that proton beam radiation therapy lacks sufficient clinical evidence — by the standards in its clinical policy bulletin — to be considered proven and non-experimental for your specific cancer type, stage, or treatment setting. Aetna has historically categorized proton therapy as experimental or investigational for a range of indications where randomized controlled trial data comparing it to conventional radiation is limited.

This is one of the most actively litigated and appealed categories in radiation oncology coverage. Proton therapy has FDA clearance as a radiation delivery modality, is offered at major academic medical centers nationwide, and is supported by substantial observational and dosimetric evidence for many indications. Whether it is "experimental" under your plan turns on the specific language in Aetna's policy and how that language applies to your diagnosis — and that determination can be challenged.

## Federal Appeal Rights

• Internal appeal (ACA §2719 / ERISA §503): You are entitled to a full-and-fair internal review. The denial letter must cite the specific evidence standard your case allegedly fails to meet.
• External review (ACA §2719): ACA-compliant plans are required to offer independent external review for experimental/investigational denials — this is a particularly important right here because an independent physician reviewer applies clinical judgment, not just the plan's proprietary evidence standard. File within the timeframe in your denial letter, generally within four months of the final internal denial.
• Expedited review: If your treatment is urgent or your condition is rapidly progressing, request expedited external review — decisions are required on an accelerated timeline.

## Documentation to Gather

• Radiation oncologist's medical-necessity and non-experimental letter: A detailed letter addressing each element of Aetna's experimental/investigational definition and explaining why proton therapy is an accepted standard or accepted alternative standard of care for your specific indication at leading institutions.
• Peer-reviewed literature: Published studies (your radiation oncologist can identify these) supporting proton therapy for your cancer type and stage — without asserting specific statistics yourself; let your physician's letter carry the evidentiary weight.
• Applicable guideline organization support: Documentation that the relevant guideline body (e.g., NCCN, ASTRO, or applicable specialty society) includes proton therapy as a recognized option for your indication.
• Institutional utilization: Evidence that proton therapy for your indication is routinely offered at NCI-designated cancer centers or equivalent academic institutions.
• Tumor board recommendation: Multidisciplinary team documentation recommending proton therapy for your case.

## Criteria-Mapping Structure

Obtain Aetna's current clinical policy bulletin on proton beam radiation therapy. Identify the specific criteria used to define "experimental" or "investigational" — typically language about peer-reviewed evidence, FDA approval status, and guideline recognition. Respond to each criterion:

| Experimental/Investigational Criterion | Your Evidence | |---|---| | Sufficient peer-reviewed evidence | Prescriber's literature summary | | Recognition in applicable guidelines | NCCN / ASTRO guideline reference | | Offered at recognized institutions | Institutional utilization statement | | FDA clearance of modality | Confirm proton therapy's FDA status via prescriber |

The exact policy language governs — obtain the current version of Aetna's bulletin and your plan's evidence standards before submitting your appeal.